Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-057310

Chief Commercial Officer bought 30,000 shares at $1.84 ($55,200)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kirby Daniel Gordon Chief Commercial Officer 2025-06-05 Purchase +30,000 $1.84 $55,200 30,000 D: show line 1 in the form
Open-market purchases · 30,000 sh · avg $1.84 · $55,200
Loading xslF345X05/tm2517335-1_4seq1.xml…